Mr Julian Merz
University of Freiburg, Freiburg (Germany)
Knockout of purinergic receptor Y13 (P2Y13) results in an improved outcome of metabolic syndrome in mice
Event: ESC Congress 2020
Topic: Lipid Metabolism, Metabolic Syndrome, Diabetes
Session: Advances in Lipids and Cardiovascular Diseases
Post-myocardial infarction activation of P2X7 dependent inflammasome is crucial to develop an appropriate scar integrity
Event: ESC Congress 2019
Topic: Fibrosis
Session: Molecular mechanisms of cardiovascular inflammation
Knockout of purinergic receptor Y13 (P2Y13) results in an improved outcome in metabolic syndrome in mice
Event: ESC Congress 2019
Topic: Lipid Metabolism, Metabolic Syndrome, Diabetes
Session: Metabolic interfaces in vascular disease
The role of the purinergic receptor p2x7 in the pathogenesis of atherosclerosis
Event: ESC Congress 2017
Topic: Atherosclerosis
Session: Atherogenesis - New mechanisms
ESC 365 is supported by
